$INVXNeutralLow

Reddout Mark sold $301K of INVX

Reddout Mark (President of North America) sold 10,750 shares of Innovex International, Inc. (INVX) at $28.00 ($0.30M total) on 2026-06-02 under a Rule 10b5-1 trading plan.

6/10
3/10
Low
Neutral
After-hours SEC Form 4 filed 2026-06-03 for a 2026-06-02 sale.
Neutral-to-slightly negative (insider selling), but likely already discounted due to 10b5-1.

Insider selling can modestly affect sentiment, but this is a small, likely routine disclosure under a 10b5-1 plan.

Innovex International officer Mark Reddout sold 10,750 shares in an open-market transaction disclosed on SEC Form 4.

Limited near-term impact; any reaction is likely muted given the pre-arranged 10b5-1 context.

Background

This is an SEC Form 4 insider transaction disclosure (officer/direct holdings) for Innovex International, Inc.

Why it matters

The disclosure provides incremental sentiment information but is not a fundamental catalyst; 10b5-1 plans generally weaken the predictive value of insider sales.

Market relevance

Traders may note the insider sale for sentiment monitoring, but the 10b5-1 designation suggests low incremental risk to the stock’s fundamentals.

Market effects

No clear sector read-through from a single small insider sale.

None indicated.

None indicated.

Alternative perspectives

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations.

The filing does not indicate whether other insiders or institutions changed positions around the same time, limiting inference from this one transaction.

Key entities

  • Innovex International, Inc.

    Subject of the Form 4 insider sale by officer Mark Reddout.

  • Mark Reddout

    President of North America who sold 10,750 shares at $28.00/share under a 10b5-1 plan.

Related articles

$INVXHigh

Innovex International (NYSE:INVX) Surges Over 7% After Q1 Earnings Beat

Innovex International (NYSE:INVX) reported Q1 2026 results that surpassed analyst expectations for both revenue and earnings per share, leading to a significant surge of over 7.7% in after-market trading. The company highlighted strong operational execution, early benefits from cost-saving initiatives, and robust free cash flow generation despite a sequential dip in revenue. While Q2 guidance is slightly below Wall Street projections due to anticipated less favorable product mix and potential Middle East disruptions, investors focused on improving margins, a debt-free balance sheet, and strategic wins like new subsea projects and the DIS acquisition.

$INVXMed

Follow-on Offering and Buyback Combo Could Be A Game Changer For Innovex International (INVX)

Innovex International (INVX) recently completed a US$148.06 million follow-on offering of common shares combined with a company share repurchase. This financial maneuver is expected to reshape the company's ownership structure and sharpens the focus on capital allocation and execution, especially considering recent reports of higher 2025 sales but lower net income. Investors are advised to consider the implications for Innovex's investment narrative, particularly the impact on its valuation and future performance.

$INVXMed

Innovex International, Inc. SEC 10-K Report

Innovex International, Inc. has released its 2025 10-K report, showcasing significant financial growth with revenues up 48% to $978.3 million and operating income up 170% to $132.6 million. The company highlights strategic acquisitions, such as SCF Machining and Citadel, to expand its supply chain and strengthen its downhole technologies. Despite these successes, Innovex acknowledges challenges including market volatility, international operational risks, regulatory changes, and geopolitical uncertainties.

$INVXMed

Gabelli Funds LLC Lowers Stock Position in Innovex International, Inc. $INVX

Gabelli Funds LLC reduced its stake in Innovex International, Inc. (NYSE:INVX) by 15.3% in the second quarter, decreasing its holdings to 360,100 shares valued at $5.625 million. Despite this reduction, several other institutional investors increased their positions in INVX during the same period, including US Bancorp DE, First Horizon Advisors Inc., Smartleaf Asset Management LLC, PNC Financial Services Group Inc., and Police & Firemen s Retirement System of New Jersey. Innovex International's stock recently opened at $23.07, and the company has received a consensus "Buy" rating from analysts with an average target price of $16.50.